Skip to main content
. 2021 Apr 20;14(3):267–277. doi: 10.1007/s12195-021-00670-3

Table 2.

Days post-antibody labeling for each antibody and cell type combination when the primary antibody is diminished to 90, 80, and 70% of the starting fluorescence levels in the live proliferative condition.

Days post-labeling CD44 ASCs CD44 WI-38 s CD90 ASCs CD90 WI-38 s CD105 ASCs CD105 WI-38 s
Live Cell Ab > 90% Gone 4 5 4 1 2 3
Live Cell Ab > 80% Gone 3 4 2 1 2 1
Live Cell Ab > 70% Gone 2 3 1 1 2 1